cd38 inhibitor and 5-amino-1mq synergy nad+ Inhibition of enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism Rapid Discovery of CD38 Inhibitor
Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



